Market Cap 592.57M
Revenue (ttm) 18.14M
Net Income (ttm) -72.85M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 649,900
Avg Vol 936,122
Day's Range N/A - N/A
Shares Out 188.72M
Stochastic %K 2%
Beta 1.98
Analysts Strong Sell
Price Target $4.50

Company Profile

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reaw...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 469 0914
Address:
701 Veterans Circle, Warminster, United States
MRVivke
MRVivke May. 13 at 11:46 AM
$ABUS $179M from settlement but own 16% of Genevant who received the majority of the settlement. Is the $179 the 16% or is there 16% equity in the rest of the settlement?
0 · Reply
Blueviking
Blueviking May. 13 at 11:42 AM
$ABUS https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-reports-first-quarter-2026-financial-results-and
0 · Reply
Blueviking
Blueviking May. 13 at 11:40 AM
$ABUS Time to show us some money. We own this company (stockholders)🥳
0 · Reply
Blueviking
Blueviking May. 13 at 11:38 AM
$ABUS https://investor.arbutusbio.com/node/19541/html Holy cow🚀
0 · Reply
Kempo73
Kempo73 May. 13 at 11:33 AM
$ABUS https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-reports-first-quarter-2026-financial-results-and
0 · Reply
Nile1
Nile1 May. 13 at 11:31 AM
$ABUS PR just released
0 · Reply
solidflo
solidflo May. 12 at 8:39 PM
$ABUS If they issue a special dividend what criteria pertaining to the date of stock ownership would be required to receive this so called dividend? Right most dividends have a ex-dividend date generally closer to earning release and prior to payout date.
0 · Reply
Mountainmannn
Mountainmannn May. 12 at 8:05 PM
$ABUS Long-Term investors turn on DRIP for when or if a special dividend is issued for the settlement he gets directly reinvested to the company! Or buy shares when you get the payout
1 · Reply
LM_Johanssen
LM_Johanssen May. 12 at 8:00 PM
$ABUS interesting close for a Monday
1 · Reply
Mountainmannn
Mountainmannn May. 12 at 7:52 PM
$ABUS lol cracks me up management wants more money when a settlement payout is coming.. where was our vote for ok r against the settlement? I guess they are saying that falls under their fiduciary responsibilities and opinions.. still like the opportunities this company has to offer. Just wanting an investment group to take over the board or in house ownership if that were possible. Maybe the investment groups can get more involved here on board and company decisions movement strategies.
1 · Reply
Latest News on ABUS
Why Is Moderna (MRNA) Stock Surging Today, 3/4/26?

2026-03-04T16:55:47.000Z - 2 months ago

Why Is Moderna (MRNA) Stock Surging Today, 3/4/26?

MRNA


Unusually active option classes on open March 4th

2026-03-04T14:40:55.000Z - 2 months ago

Unusually active option classes on open March 4th

AAOI ANF DVN F NU PLUG POET


Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)

2025-11-13T12:41:19.000Z - 6 months ago

Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)


Arbutus Provides 2025 Corporate and Financial Update

Jan 13, 2025, 7:30 AM EST - 1 year ago

Arbutus Provides 2025 Corporate and Financial Update


Arbutus Biopharma Transcript: Status Update

Dec 3, 2024, 11:00 AM EST - 1 year ago

Arbutus Biopharma Transcript: Status Update


Arbutus to Present at Jefferies London Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Arbutus to Present at Jefferies London Healthcare Conference


Arbutus Biopharma Earnings Call Transcript: Q3 2024

Nov 6, 2024, 8:45 AM EST - 1 year ago

Arbutus Biopharma Earnings Call Transcript: Q3 2024


Arbutus to Participate in Two Upcoming Investor Conferences

Sep 3, 2024, 7:30 AM EDT - 1 year ago

Arbutus to Participate in Two Upcoming Investor Conferences


Arbutus Biopharma Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:45 AM EDT - 1 year ago

Arbutus Biopharma Earnings Call Transcript: Q2 2024


Arbutus Distributors Ltd. News Release

Jun 3, 2024, 9:50 AM EDT - 2 years ago

Arbutus Distributors Ltd. News Release


Arbutus to Present Imdusiran Data at EASL Congress 2024

May 22, 2024, 2:00 AM EDT - 2 years ago

Arbutus to Present Imdusiran Data at EASL Congress 2024


Arbutus Biopharma Earnings Call Transcript: Q1 2024

May 2, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q1 2024


Arbutus Biopharma Earnings Call Transcript: Q4 2023

Feb 29, 2024, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q4 2023


Arbutus Biopharma Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q3 2023


Arbutus Biopharma Earnings Call Transcript: Q2 2023

Aug 3, 2023, 8:45 AM EDT - 3 years ago

Arbutus Biopharma Earnings Call Transcript: Q2 2023


MRVivke
MRVivke May. 13 at 11:46 AM
$ABUS $179M from settlement but own 16% of Genevant who received the majority of the settlement. Is the $179 the 16% or is there 16% equity in the rest of the settlement?
0 · Reply
Blueviking
Blueviking May. 13 at 11:42 AM
$ABUS https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-reports-first-quarter-2026-financial-results-and
0 · Reply
Blueviking
Blueviking May. 13 at 11:40 AM
$ABUS Time to show us some money. We own this company (stockholders)🥳
0 · Reply
Blueviking
Blueviking May. 13 at 11:38 AM
$ABUS https://investor.arbutusbio.com/node/19541/html Holy cow🚀
0 · Reply
Kempo73
Kempo73 May. 13 at 11:33 AM
$ABUS https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-reports-first-quarter-2026-financial-results-and
0 · Reply
Nile1
Nile1 May. 13 at 11:31 AM
$ABUS PR just released
0 · Reply
solidflo
solidflo May. 12 at 8:39 PM
$ABUS If they issue a special dividend what criteria pertaining to the date of stock ownership would be required to receive this so called dividend? Right most dividends have a ex-dividend date generally closer to earning release and prior to payout date.
0 · Reply
Mountainmannn
Mountainmannn May. 12 at 8:05 PM
$ABUS Long-Term investors turn on DRIP for when or if a special dividend is issued for the settlement he gets directly reinvested to the company! Or buy shares when you get the payout
1 · Reply
LM_Johanssen
LM_Johanssen May. 12 at 8:00 PM
$ABUS interesting close for a Monday
1 · Reply
Mountainmannn
Mountainmannn May. 12 at 7:52 PM
$ABUS lol cracks me up management wants more money when a settlement payout is coming.. where was our vote for ok r against the settlement? I guess they are saying that falls under their fiduciary responsibilities and opinions.. still like the opportunities this company has to offer. Just wanting an investment group to take over the board or in house ownership if that were possible. Maybe the investment groups can get more involved here on board and company decisions movement strategies.
1 · Reply
Thepatientone
Thepatientone May. 12 at 5:57 PM
$ABUS The shareholders meeting on the 26th, can it be attended virtually? I would appreciate the link if you have it.
1 · Reply
Thepatientone
Thepatientone May. 12 at 5:50 PM
$ABUS - Also the decency to asks for 16M more shares to allocate to management. Please vote No and do you all want me to draft a letter to Whitefort since the board is occupied by Roivant. We either need to accelerate HBV or promote to major pharma without Roivant intervention.
3 · Reply
Grtgooglymoogly
Grtgooglymoogly May. 12 at 4:57 PM
$ABUS There's an abstract release and embargo lift of the EASL abstracts that are non-late-breaking. No idea if this even applies to ABUS. It's 8am CET time, so 1am eastern time, midnight central time. Trying to follow Abus' science, or lack there of, is just an invitation to hate.
0 · Reply
Heavey
Heavey May. 12 at 4:54 PM
$ABUS short interest decreased marginally
0 · Reply
CapitalismUSA
CapitalismUSA May. 12 at 2:17 PM
$ABUS $ABUS Androski was Founder/President of Roivant Social Ventures before joining Arbutus as President, CEO, Board Chair. Waaaaaay under qualified for this role. However, ROIV knew they could control her in this role. Criminal collusion IMO.
2 · Reply
renoH4
renoH4 May. 12 at 1:47 PM
$ABUS ..to manipulate a share price, you need only a seller , a buyer and a corrupt market maker. If you really want, you can take them to court - ask some special attorney and you have the chance to win the Class-action lawsuit - now it is to early but in some months we could start to fight. And i am sure we have some big investors, institutions and banks on our side. Due to this background we buy every dip.
2 · Reply
NakdEnergy
NakdEnergy May. 12 at 12:14 PM
$ABUS I really believe this was and is an orchestrated screw job of the retail shareholders. Ousting the original management was the bull horn we should have listened to. $ROIV has been pulling the strings the whole time and ‘will not’ allow any settlement that would ruin their ‘Big Pharma’ relationships. This is Wall Street crookedness at its best because they did it in a way ‘all out front’ that no body could successfully take them to court. We wasted years of putting good capital to work and when we finally force a settlement, “The Stock Goes Down” You can’t make this crap up! Hope all those retail investors do well in their other investments! We deserved better IMO!
2 · Reply
sheepmanct
sheepmanct May. 11 at 9:20 PM
$ABUS ROIV earnings will be on 5/20. Call will be at 800am ET. Press release is usually released at 700am. IMVT (Immunovant) releasing same day and time. Maybe ABUS on 5/20? https://investor.roivant.com/news-releases/news-release-details/roivant-report-financial-results-fourth-quarter-and-fiscal-2/
1 · Reply
Grtgooglymoogly
Grtgooglymoogly May. 11 at 5:41 PM
$ABUS So, Abus'll never again participate in an investor conference?
1 · Reply
Buqqets
Buqqets May. 11 at 2:27 PM
$ABUS chart looks good.....again.
1 · Reply
Heavey
Heavey May. 10 at 8:00 AM
$ABUS yet to receive my opportunity to vote in the 2026 Omnibus Share Plan, but good to see Whitefort are doing the right thing by us all.
2 · Reply
Grtgooglymoogly
Grtgooglymoogly May. 9 at 3:28 PM
$ABUS What's confusing about the jump in institutional ownership is that three new Vanguard "entities" bought a total of about 8 million shares between them......What's funny (and disgusting) is that Jeffries bought 1.894 million shares last quarter, then they put out a hit piece saying upside was limited.....i'm gonna assume they want more shares.
2 · Reply